73 articles
Gregg Sylvester, MD, Chief Medical Officer at Seqirus, one of the world’s largest influenza vaccine providers discusses some new real-world evidenc...
Jessica Solis-McCarthy, MD, FACEP, emergency medicine physician at UT Health San Antonio and University Hospital and spokesperson for the American Colle...
Joaquin Mould-Quevedo, Global Pricing and Health Economics Director at Seqirus, a global leader in seasonal influenza prevention and pandemic influenza ...
Michael Agadjanyan is Vice President, Professor and Head of the Department of Molecular Immunology at the Institute for Molecular Medicine (IMM), Huntin...
Derek Wallace, Vice President and Dengue Global Program Lead at Takeda, discusses the first public presentation of long-term safety and efficacy resul...
Jeremy Levin, Chairman and CEO of Ovid Therapeutics, Inc., and former chairman of the global Biotechnology Innovation Organization (BIO) discusses the n...
Ellie Stang, a board-certified pediatrician and founder and CEO of ProgenyHealth, a healthcare company that applies evidence-based care management solut...
Jonathan Edelman, MD, Vice President, Clinical Development at Seqirus discusses the Phase 3 clinical data presented at the 2021 Pediatric Academic Socie...
Dave Ross, VP of Commercial Operations - North America at Seqirus discusses the recent FDA approval of FLUCELVAX® QUADRIVALENT, Seqirus’ cell-based q...
Suzanne Graney, Executive Director at Four Diamonds, a pediatric cancer charity, discusses the work the organization is doing to conquer childhood cance...